CARERATING2023-10-012023-12-31 CARERATING2023-10-012023-12-31 CARERATING2023-10-012023-12-31in-bse-fin:OneOperatingExpenses01Member CARERATING2023-10-012023-12-31in-bse-fin:FourOperatingExpenses01Member CARERATING2023-12-31 CARERATING2023-10-012023-12-31in-bse-fin:OneReportableSegmentRevenue01Member CARERATING2023-10-012023-12-31in-bse-fin:OneReportableSegmentRevenue02Member CARERATING2023-10-012023-12-31in-bse-fin:FourReportableSegmentRevenue01Member CARERATING2023-10-012023-12-31in-bse-fin:FourReportableSegmentRevenue02Member CARERATING2023-10-012023-12-31in-bse-fin:OneReportableSegmentResults01Member CARERATING2023-10-012023-12-31in-bse-fin:OneReportableSegmentResults02Member CARERATING2023-10-012023-12-31in-bse-fin:FourReportableSegmentResults01Member CARERATING2023-10-012023-12-31in-bse-fin:FourReportableSegmentResults02Member CARERATING2023-10-012023-12-31in-bse-fin:OneReportableSegmentAssets01Member CARERATING2023-10-012023-12-31in-bse-fin:OneReportableSegmentAssets02Member CARERATING2023-10-012023-12-31in-bse-fin:OneReportableSegmentLiabilities01Member CARERATING2023-12-31in-bse-fin:OneReportableSegmentLiabilities01Member CARERATING2023-10-012023-12-31in-bse-fin:OneReportableSegmentLiabilities02Member CARERATING2023-12-31in-bse-fin:OneReportableSegmentLiabilities02Member CARERATING2023-10-012023-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member CARERATING2023-10-012023-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member CARERATING2023-10-012023-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member CARERATING2023-10-012023-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 534804 CARERATING NA CARE Ratings Limited Equity 2023-04-01 2024-03-31 2024-01-24 2024-01-15 INR Lakhs Third quarter 14:00:00 19:30:00 2024-01-24 2024-01-24 Not applicable Multi segment 2023-10-01 2023-12-31 Unaudited Consolidated 786767000.00 136825000.00 923592000.00 0.00 0.00 0.00 425064000.00 4689000.00 26049000.00 128152000.00 583953000.00 339639000.00 0.00 339639000.00 101652000.00 -1253000.00 100399000.00 0.00 239240000.00 0.00 0.00 0.00 0.00 239240000.00 -2532000.00 236709000.00 234558000.00 4681000.00 -2603000.00 73000.00 297730000.00 10 7.88 7.85 0.00 0.00 7.88 7.85 1. The above results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at its meeting held on January 24, 2024 and have been subjected to limited review by the statutory auditors of the Company. 2. The consolidated financial results include results of CARE Ratings Limited and its subsidiaries namely CARE Analytics and Advisory Private Limited (formerly known as CARE Risk Solutions Private Limited), CARE ESG Ratings Limited (formerly known as CARE Advisory Research and Training Limited), CARE Ratings (Africa) Private Limited and CARE Ratings Nepal Limited. 3. The accompanying financial results have been prepared as per the format prescribed under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as modified by Circular No. CIR/CFD/FAC/62/2016. 4. The financial results have been prepared in accordance with the applicable accounting standards, as modified under the Companies (Indian Accounting Standards) Rules, 2015 and as specified in section 133 of the Companies Act. 5. The Company has granted a) 5,00,000 options on October 13, 2020, b) 3,22,000 options on December 01, 2020, c) 1,23,500 options on October 29, 2021, d) 25,000 options on May 28, 2022, e) 1,00,000 options on July 29, 2022, f) 72,000 options on November 8, 2022, g) 10,000 options on January 04, 2023, h) 1,05,000 options on September 27, 2023 and i) 6,000 options on September 30, 2023 to the eligible employees as the Company's Employees Stock Option Scheme (ESOS) 2020 duly approved by shareholders in AGM and Nomination and Remuneration Committee. The closing balance of options as on 31st December, 2023 are 4,23,211. As per Ind AS 102 - Share Based Payment, total cost of ESOP will be charged over vesting period, accordingly the Employee Benefit Expenses in standalone results includes ESOP charge under respective periods as under: As required by Ind AS 36 Impairment of Assets , based on the assessment of impairment of investment in a subsidiary, the Company has recognised impairment loss of INR 3.50 crores in the standalone financial results for the quarter ended 31 December 2023. Such impairment loss does not impact consolidated financial results. Multi segment 2023-04-01 2023-12-31 Unaudited Consolidated 2415368000.00 364025000.00 2779393000.00 0.00 0.00 0.00 1213433000.00 12556000.00 78099000.00 370928000.00 1675016000.00 1104377000.00 0.00 1104377000.00 318491000.00 5753000.00 324244000.00 0.00 780133000.00 0.00 0.00 0.00 0.00 780133000.00 -1847000.00 778287000.00 764400000.00 15733000.00 -2201000.00 354000.00 297730000.00 10 25.71 25.64 0.00 0.00 25.71 25.64 Other Expenses 128152000.00 Other Expenses 370928000.00 Others 82961000.00 Ratings and related services 704085000.00 Others 220494000.00 Ratings and related services 2196861000.00 787046000.00 2417354000.00 279000.00 1986000.00 786767000.00 2415368000.00 Others -58316000.00 Ratings and related services 265818000.00 Others -169165000.00 Ratings and related services 922074000.00 207502000.00 752909000.00 4689000.00 12556000.00 -136825000.00 -364025000.00 339638000.00 1104377000.00 Others 579669000.00 Ratings and related services 7167720000.00 7747389000.00 467996000.00 8215385000.00 Others 215271000.00 Ratings and related services 1097157000.00 1312428000.00 0.00 1312428000.00 Items that will not be reclassified to profit or Loss -3645000.00 Items that will not be reclassified to profit or Loss -4408000.00 -3645000.00 -4408000.00 -780000.00 -951000.00 Items that will be reclassified to profit or Loss 333000.00 Items that will be reclassified to profit or Loss 1611000.00 333000.00 1611000.00 0.00 0.00